Evidence map›Paper›PMID 26810757›Full record

ArticleBMC neuroscience2016

Engraftment of enteric neural progenitor cells into the injured adult brain.

Jaime Belkind-Gerson, Ryo Hotta, Michael Whalen, Naema Nayyar, Nandor Nagy, Lily Cheng, Aaron Zuckerman, Allan M Goldstein, Jorg Dietrich

Abstract read
In one paragraph

Article in BMC neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jaime Belkind-GersonDepartment of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. jbelkindgerson@mgh.harvard.edu.
Ryo HottaDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. rhotta@mgh.harvard.edu.
Michael WhalenDepartment of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. mwhalen@mgh.harvard.edu.
Naema NayyarDepartment of Neurology, Division of Neuro-Oncology, and Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. nnayyar@partners.org.
Nandor NagyDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. nnagy@mgh.harvard.edu.
Lily ChengDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. lscheng@mgh.harvard.edu.
Aaron ZuckermanDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. zuckermana@wustl.edu.
Allan M GoldsteinDepartment of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. amgoldstein@mgh.harvard.edu.
Jorg DietrichDepartment of Neurology, Division of Neuro-Oncology, and Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. jdietrich1@partners.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA major area of unmet need is the development of strategies to restore neuronal network systems and to recover brain function in patients with neurological disease. The use of cell-based therapies remains an attractive approach, but its application has been challenging due to the lack of suitable cell sources, ethical concerns, and immune-mediated tissue rejection. We propose an innovative approach that utilizes gut-derived neural tissue for cell-based therapies following focal or diffuse central nervous system injury.

resultsEnteric neuronal stem and progenitor cells, able to differentiate into neuronal and glial lineages, were isolated from the postnatal enteric nervous system and propagated in vitro. Gut-derived neural progenitors, genetically engineered to express fluorescent proteins, were transplanted into the injured brain of adult mice. Using different models of brain injury in combination with either local or systemic cell delivery, we show that transplanted enteric neuronal progenitor cells survive, proliferate, and differentiate into neuronal and glial lineages in vivo. Moreover, transplanted cells migrate extensively along neuronal pathways and appear to modulate the local microenvironment to stimulate endogenous neurogenesis.

conclusionsOur findings suggest that enteric nervous system derived cells represent a potential source for tissue regeneration in the central nervous system. Further studies are needed to validate these findings and to explore whether autologous gut-derived cell transplantation into the injured brain can result in functional neurologic recovery.

Indexed as

AnimalsBrainBrain InjuriesCell ProliferationCells, CulturedCell SurvivalCell TransplantationEnteric Nervous SystemMiceMice, Inbred C57BLNeural Stem CellsNeurogenesisRadiation Injuries, ExperimentalStem Cell Transplantation

Identifiers

PMID26810757
PMCPMC4727306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.